Research graph
References from Associations of [ 18 F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in Cognitively Unimpaired Older Adults. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1097/nen.0b013e318232a379
10.1097/nen.0b013e318232a379 · External reference
Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy
10.1001/jamaneurol.2020.2526 · 2020 · External reference
10.1007/s00259-019-04397-2
10.1007/s00259-019-04397-2 · External reference
10.1007/s00401-023-02672-z
10.1007/s00401-023-02672-z · External reference
10.1186/s13195-022-01048-x
10.1186/s13195-022-01048-x · External reference
10.2967/jnumed.119.236224
10.2967/jnumed.119.236224 · External reference
10.1007/s00259-020-04923-7
10.1007/s00259-020-04923-7 · External reference
Establishing tau-PET cut-points for cognitive diagnosis with 18F-PI-2620 in a multi-ethnoracial cohort
10.1162/imag.a.41 · 2025 · External reference
10.2967/jnumed.118.224113
10.2967/jnumed.118.224113 · External reference
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions
10.1007/s00259-025-07199-x · 2025 · External reference
10.2967/jnumed.123.265856
10.2967/jnumed.123.265856 · External reference
[18F]PI-2620 tau PET signal across the aging and Alzheimer’s disease clinical spectrum
10.1162/imag_a_00329 · 2024 · External reference
Elevated tau in the piriform cortex in Alzheimer’s but not Parkinson’s disease using PET-MR
10.1002/dad2.70040 · 2024 · External reference
10.1093/brain/awab092
10.1093/brain/awab092 · External reference
10.1016/j.neurobiolaging.2020.09.017
10.1016/j.neurobiolaging.2020.09.017 · External reference
10.1212/wnl.0000000000007739
10.1212/wnl.0000000000007739 · External reference
10.1523/jneurosci.2028-17.2017
10.1523/jneurosci.2028-17.2017 · External reference
10.1038/s41380-018-0342-8
10.1038/s41380-018-0342-8 · External reference
10.1038/s41598-019-47638-y
10.1038/s41598-019-47638-y · External reference
Vascular contributions to cognitive decline: beyond amyloid and tau in the Harvard Aging Brain Study
10.1177/0271678x241237624 · 2024 · External reference
A physically and mentally active lifestyle relates to younger brain and cognitive age
10.1007/s11357-025-01764-w · 2026 · External reference
10.1186/s13195-024-01603-8
10.1186/s13195-024-01603-8 · External reference
10.1097/01.wcb.0000085441.37552.ca
10.1097/01.wcb.0000085441.37552.ca · External reference
Multicenter 18F-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease
10.3390/biom12030458 · 2022 · External reference
10.1007/s12021-018-9384-y
10.1007/s12021-018-9384-y · External reference
10.1016/j.jalz.2016.08.005
10.1016/j.jalz.2016.08.005 · External reference
Direct comparison between 18F-flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
10.1016/j.neuroimage.2024.120509 · 2024 · External reference
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies
10.1007/s00401-024-02834-7 · 2024 · External reference
Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
10.1007/s00259-025-07396-8 · 2025 · External reference
Hybrid tau-PET/MRI study: quantitative susceptibility mapping in progressive supranuclear palsy and its correlation with tau-PET
10.1007/s00259-025-07600-9 · 2026 · External reference
10.1016/j.neuroimage.2022.119761
10.1016/j.neuroimage.2022.119761 · External reference
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
10.1038/s41593-025-02000-6 · 2025 · External reference
10.1007/s00259-021-05195-5
10.1007/s00259-021-05195-5 · External reference
Assessment of [18F]PI-2620 tau-PET quantification via non-invasive automatized image derived input function
10.1007/s00259-024-06741-7 · 2024 · External reference
Contribution of extracerebral tracer retention and partial volume effects to sex differences in flortaucipir-PET signal
10.1177/0271678x231196978 · 2024 · External reference
Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults
10.1001/jamaneurol.2018.4693 · 2019 · External reference
10.1093/brain/awaa327
10.1093/brain/awaa327 · External reference
Sex differences in off-target binding using tau positron emission tomography
10.1016/j.nicl.2021.102708 · 2021 · External reference
10.2967/jnumed.122.263948
10.2967/jnumed.122.263948 · External reference
10.1212/wnl.0000000000004425
10.1212/wnl.0000000000004425 · External reference
Association of apolipoprotein E ε4 with medial temporal tau independent of amyloid-β
10.1001/jamaneurol.2019.4421 · 2020 · External reference
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
10.1038/s43587-025-00835-z · 2025 · External reference
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
10.1038/s43587-022-00310-z · 2022 · External reference
Classification and prediction of cognitive performance differences in older age based on brain network patterns using a machine learning approach
10.1162/netn_a_00275 · 2023 · External reference
